Umetrics Suite Blog

Is Your Company Ready for Digital Transformation and Biopharma 4.0?

May 19, 2020

From employing artificial intelligence (AI) to identify drug candidates to using big data to support continuous process manufacturing, the prospects for digital transformation in the biopharma industry are huge. Yet, biopharma and life sciences lag behind many other industries when it comes to digital transformation.

Read More

Avoid Costly and Dangerous Process Deviations by Using Real-Time Data Analytics

March 5, 2020

Out of control processes in pharma manufacturing are not something to take lightly. If your production runs are seeing frequent deviations, leading to expensive batch losses or frequent rework, it’s time to take a look at ways to correct any process deviations in a more expedient manner. Uncorrected deviations or processes that vary from approved process parameters can lead to costly and dangerous mistakes.

Read More

Correcting the Most Common Causes of Pharma Process Deviations

February 27, 2020

Keeping your pharmaceutical manufacturing processes under control is important not only to ensure a quality product, but also for regulatory compliance. Process or raw material deviations can affect the downstream quality of a product and could mean tossing out an entire batch or end product if process corrections aren’t made soon enough — or if you can’t document that a correction was made before it affected your critical quality attributes.

Read More

Seven Common Causes of Pharma Process Deviations

February 5, 2020

For pharmaceutical manufacturers, a process deviation may not only mean a bad batch that affects a downstream process, it can also risk a regulatory violation that leads to fines or expensive market setback, or worse, it could endanger the health of the patient.

Read More

Using Multivariate Models in a Regulated Environment for Continuous Manufacturing of Pharmaceuticals

January 14, 2020

Continuous manufacturing is one of the key trends within the pharmaceutical industry, both for the production of ‘classical’ drugs as well as large molecules. Companies are looking for ways to shift from traditional batch processing to a continuous method of operation. The main advantages associated with these processes are more room for modularity, automation and flexibility due to a smaller footprint, as well as more consistent quality of the drug product.

Read More

Digital Twins Offer a Data-Based Approach to More Effective Biopharma Process Control

December 11, 2019

For pharmaceutical companies facing challenges such as rising costs, sterner regulations and declining profit margins, innovative new technologies like artificial intelligence (AI) and digital twins have become part of an essential strategy to future-proof their businesses. A digital twin is the next evolution of machine learning combining advanced data analytics and equipment simulation with comprehensive system models that blend historical information with real-time data to predict the future of a process. According to Gartner, the digital twin concept was one of the top 10 strategic technology trends in 2019.

Read More

Which Data Analytics Methods Best Support a Quality by Design Approach for Biosimilars?

November 12, 2019

Biosimilars are an exciting route to increasing access to the highly effective therapy made possible by biologics, but ensuring a biosimilar meets the critical quality attributes (CQA) of the original biologic is a major challenge. Optimizing production at full scale is impractical, which makes a quality by design (QbD) approach using a reliable scale down model of the process an attractive alternative. A process development team at Zhejiang Hisun Pharmaceuticals, Taizhou, China, therefore developed a scaled down model of the cell culture process used to produce the biosimilar adalimumab. They qualified the model using multivariate data analysis (SIMCA), and explored the design space for key process attributes (KPA) and CQAs using MODDE.

Read More

The Trending Role of Artificial Intelligence in the Pharmaceutical Industry

September 26, 2019

Over the last several years, the use of artificial intelligence (AI) in the pharma and biomedical industry has gone from science fiction to science fact. Increasingly, pharma and biotech companies are adopting more efficient, automated processes that incorporate data-driven decisions and use predictive analytics tools. The next evolution of this approach to advanced data analytics incorporates artificial intelligence and machine learning.

Read More

How One Company Integrated Data to Implement Real-Time Bioprocess Monitoring

September 4, 2019

Most biopharma manufacturing companies are keen to adopt new methods that would streamline production, reduce errors and ensure product quality. That was the goal of Bristol-Myers Squibb when they implemented a complex real-time process monitoring system that involved integrating data from a number of different technologies, systems and vendors to gain greater control over complex batch processes.

Read More

How Digital Transformation Helped Amgen Implement Real-Time Process Control

August 6, 2019

In many manufacturing industries, variability in raw materials can lead to unexpected and undesirable changes in the final products. In regulated industries such as pharmaceuticals, this is especially problematic due to the need to maintain carefully controlled processes that stay within approved regulatory parameters for drug development and production. Embracing a total company-wide digital transformation enabled Amgen to align data across multiple systems to not only control, but also predict unacceptable deviations in time to make necessary adjustments. Read on to find out how they used data analytics to implement real-time process control.

Read More

Multivariate vs Univariate Analysis in the Pharma Industry: Analyzing Complex Data

June 18, 2019

The pharmaceutical industry, including R&D, manufacturing and also product sales and use, creates a lot of data. The question is, what can we do to understand our data better, get more out of it, and unlock its potential in the most rational way possible to get to the knowledge we need? And how can we gain control over our research, or the processes needed to generate a stable, reliable product that consistently meets regulatory requirements? The answer is Multivariate Data Analysis.

Read More

Using advanced data analytics to make the shift to continuous process manufacturing

April 2, 2019

Throughout the evolution of manufacturing, many industries have gradually shifted away from batch process to continuous process manufacturing as production technologies matured. This has included industries such as chemical, petroleum, steel, automobile, consumer goods and food manufacturing.

Read More

Search the Blog

    Subscribe to the Blog

    View the:

    Data Analytics Glossary of Terms

    List of Webinars

    Get a free trial